%PDF-1.5
%
1 0 obj<>
endobj
2 0 obj<>
endobj
3 0 obj<>
endobj
5 0 obj null
endobj
6 0 obj<>
endobj
7 0 obj<>
endobj
8 0 obj<>>>
endobj
9 0 obj<>
endobj
10 0 obj<><>]/C/SpdrArt/P 9 0 R/S/Article/Pg 11 0 R>>
endobj
11 0 obj<>/ProcSet[/PDF/Text]>>/StructParents 0>>
endobj
12 0 obj<>/Subtype/Link/A<>>>
endobj
13 0 obj<>/Font<>>>/DA(/Helv 0 Tf 0 g )>>
endobj
14 0 obj<>
endobj
15 0 obj<>
endobj
16 0 obj<>
endobj
17 0 obj[12 0 R 20 0 R 21 0 R 22 0 R]
endobj
18 0 obj<>
endobj
19 0 obj[10 0 R]
endobj
20 0 obj<>/Subtype/Link/A<>>>
endobj
21 0 obj<>/Subtype/Link/A<>>>
endobj
22 0 obj<>/Subtype/Link/A<>>>
endobj
23 0 obj<>/ProcSet[/PDF/Text]>>/StructParents 1>>
endobj
24 0 obj[10 0 R]
endobj
25 0 obj<>/ProcSet[/PDF/Text]>>/StructParents 2>>
endobj
26 0 obj[10 0 R]
endobj
27 0 obj<>/Subtype/Link/A<>>>
endobj
28 0 obj[27 0 R]
endobj
29 0 obj<>
endobj
30 0 obj<>
endobj
31 0 obj<>
endobj
32 0 obj<>
endobj
33 0 obj<>
endobj
34 0 obj 9351
endobj
35 0 obj<>stream
/Artifact <>BDC
0 0 0 rg
0 i
BT
/T1_0 1 Tf
0 Tc 0 Tw 0 Ts 100 Tz 0 Tr 9 0 0 9 18 780.17 Tm
(HIVInfo.us - Sustiva - efavirenz information)Tj
ET
EMC
/WebCaptureBG BMC
/WebCaptureFN <>BDC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
10 766 m
501.422 766 l
500.422 765 l
11 765 l
h
f
10 766 m
10 694.39999 l
11 695.39999 l
11 765 l
h
f
501.422 766 m
501.422 694.39999 l
500.422 695.39999 l
500.422 765 l
h
f
10 694.39999 m
501.422 694.39999 l
500.422 695.39999 l
11 695.39999 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
0 0.50197 0 rg
16 733.2 479.422 26.8 re
f
0 0 0 rg
15 761 m
496.422 761 l
495.422 760 l
16 760 l
h
f
15 761 m
15 732.2 l
16 733.2 l
16 760 l
h
f
496.422 761 m
496.422 732.2 l
495.422 733.2 l
495.422 760 l
h
f
15 732.2 m
496.422 732.2 l
495.422 733.2 l
16 733.2 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
1 1 1 rg
16 700.39999 479.422 26.8 re
f
0 0 0 rg
15 728.2 m
496.422 728.2 l
495.422 727.2 l
16 727.2 l
h
f
15 728.2 m
15 699.39999 l
16 700.39999 l
16 727.2 l
h
f
496.422 728.2 m
496.422 699.39999 l
495.422 700.39999 l
495.422 727.2 l
h
f
15 699.39999 m
496.422 699.39999 l
495.422 700.39999 l
16 700.39999 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
0.06667 0.06667 0.06667 rg
10 680.39999 m
602 680.39999 l
599 677.39999 l
13 677.39999 l
h
f
10 680.39999 m
10 36 l
13 36 l
13 677.39999 l
h
f
602 680.39999 m
602 36 l
599 36 l
599 677.39999 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
0.50197 0 0.50197 rg
18 643.39999 576 29 re
f
0.06667 0.06667 0.06667 rg
17 673.39999 m
595 673.39999 l
594 672.39999 l
18 672.39999 l
h
f
17 673.39999 m
17 642.39999 l
18 643.39999 l
18 672.39999 l
h
f
595 673.39999 m
595 642.39999 l
594 643.39999 l
594 672.39999 l
h
f
17 642.39999 m
595 642.39999 l
594 643.39999 l
18 643.39999 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
17 638.39999 m
166.24001 638.39999 l
165.24001 637.39999 l
18 637.39999 l
h
f
17 638.39999 m
17 568.39999 l
18 569.39999 l
18 637.39999 l
h
f
166.24001 638.39999 m
166.24001 568.39999 l
165.24001 569.39999 l
165.24001 637.39999 l
h
f
17 568.39999 m
166.24001 568.39999 l
165.24001 569.39999 l
18 569.39999 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
170.24001 638.39999 m
595 638.39999 l
594 637.39999 l
171.24001 637.39999 l
h
f
170.24001 638.39999 m
170.24001 568.39999 l
171.24001 569.39999 l
171.24001 637.39999 l
h
f
595 638.39999 m
595 568.39999 l
594 569.39999 l
594 637.39999 l
h
f
170.24001 568.39999 m
595 568.39999 l
594 569.39999 l
171.24001 569.39999 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
17 564.39999 m
166.24001 564.39999 l
165.24001 563.39999 l
18 563.39999 l
h
f
17 564.39999 m
17 479.39999 l
18 480.39999 l
18 563.39999 l
h
f
166.24001 564.39999 m
166.24001 479.39999 l
165.24001 480.39999 l
165.24001 563.39999 l
h
f
17 479.39999 m
166.24001 479.39999 l
165.24001 480.39999 l
18 480.39999 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
170.24001 564.39999 m
595 564.39999 l
594 563.39999 l
171.24001 563.39999 l
h
f
170.24001 564.39999 m
170.24001 479.39999 l
171.24001 480.39999 l
171.24001 563.39999 l
h
f
595 564.39999 m
595 479.39999 l
594 480.39999 l
594 563.39999 l
h
f
170.24001 479.39999 m
595 479.39999 l
594 480.39999 l
171.24001 480.39999 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
17 475.39999 m
166.24001 475.39999 l
165.24001 474.39999 l
18 474.39999 l
h
f
17 475.39999 m
17 351.92662 l
18 352.92662 l
18 474.39999 l
h
f
166.24001 475.39999 m
166.24001 351.92662 l
165.24001 352.92662 l
165.24001 474.39999 l
h
f
17 351.92662 m
166.24001 351.92662 l
165.24001 352.92662 l
18 352.92662 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
170.24001 475.39999 m
595 475.39999 l
594 474.39999 l
171.24001 474.39999 l
h
f
170.24001 475.39999 m
170.24001 351.92662 l
171.24001 352.92662 l
171.24001 474.39999 l
h
f
595 475.39999 m
595 351.92662 l
594 352.92662 l
594 474.39999 l
h
f
170.24001 351.92662 m
595 351.92662 l
594 352.92662 l
171.24001 352.92662 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
17 347.92662 m
166.24001 347.92662 l
165.24001 346.92662 l
18 346.92662 l
h
f
17 347.92662 m
17 36 l
18 36 l
18 346.92662 l
h
f
166.24001 347.92662 m
166.24001 36 l
165.24001 36 l
165.24001 346.92662 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
170.24001 347.92662 m
595 347.92662 l
594 346.92662 l
171.24001 346.92662 l
h
f
170.24001 347.92662 m
170.24001 36 l
171.24001 36 l
171.24001 346.92662 l
h
f
595 347.92662 m
595 36 l
594 36 l
594 346.92662 l
h
f
EMC
EMC
EMC
/Article <>BDC
q
0 18 612 756 re
W* n
1 1 1 rg
BT
/TT0 1 Tf
14 0 0 14 20 744.39798 Tm
(HIVInfo.us )Tj
10.76923 0 0 10.76923 93.12199 744.39798 Tm
(presents)Tj
0 0 0 rg
14 0 0 14 20 711.59798 Tm
(An HIV Information Site & HIV Educational Resource Site \(HIS & HERS\))Tj
1 1 1 rg
17.5 0 0 17.5 22 653.89748 Tm
(Sustiva - efavirenz)Tj
0 0 0 rg
15 0 0 15 22 608.96927 Tm
(General )Tj
0 -1.2 TD
(Information)Tj
/TT1 1 Tf
12.5 0 0 12.5 175.24001 622.70221 Tm
(This drug is almost always used as one component of a multidrug )Tj
T*
(combination to suppress the human immunodeficiency \(HIV\) viral load. \
It )Tj
T*
(does not eliminate HIV; it keeps HIV suppressed so low that the virus )Tj
T*
(does not do damage as it normally would.)Tj
/TT0 1 Tf
15 0 0 15 22 518.46927 Tm
(Specifics)Tj
/TT1 1 Tf
12.5 0 0 12.5 175.24001 548.70221 Tm
(Efavirenz has been used for several years to treat HIV. According to )Tj
T*
(many experts, efavirenz may be as potent as a protease inhibitor. It ac\
ts )Tj
T*
(by preventing the formation of HIV genetic material. It is classified a\
s a )Tj
T*
(nonnucleoside reverse transcriptase inhibitor \(NNRTI\) or "non-nuke." \
)Tj
T*
(Efavirenz is considered to be one of the "gold standards" of HIV treatme\
nt.)Tj
/TT0 1 Tf
15 0 0 15 22 410.23257 Tm
(Dosing)Tj
/TT1 1 Tf
12.92308 0 0 12.92308 175.24001 459.34013 Tm
(Generally efavirenz is taken as 600 mg once a day just before you go to \
)Tj
T*
(bed. However, some people prefer to take it in the morning. Either )Tj
0 -1.26631 TD
(time is acceptable; it is important that you find the right time to suit\
you.)Tj
/T1_0 1 Tf
14 0 0 14 581.06339 427.46786 Tm
( )Tj
/TT0 1 Tf
12.92308 0 0 12.92308 175.24001 393.09044 Tm
(It is generally important that you take efavirenz on an empty )Tj
0 -1.22711 TD
(stomach.)Tj
/TT1 1 Tf
( Food will increase the absorption of the drug and give you )Tj
0 -1.2271 TD
(more side effects \(see the Side Effects section below\))Tj
/TT0 1 Tf
14 0 0 14 22 247.14581 Tm
(Adherence)Tj
18.75 0 0 18.75 94.35201 247.14581 Tm
( )Tj
/TT1 1 Tf
12.5 0 0 12.5 22 229.96146 Tm
(\(this refers to your )Tj
0 -1.2 TD
(willingness, ability, and )Tj
T*
(actual performance in )Tj
0 -1.29413 TD
(taking your medications\))Tj
/T1_0 1 Tf
14 0 0 14 157.46249 183.78479 Tm
( )Tj
/TT1 1 Tf
12.92308 0 0 12.92308 22 149.09938 Tm
(For further information )Tj
0 -1.2 TD
(and tips on adherence, )Tj
T*
(go to the )Tj
0.50197 0 0.50197 rg
/TT0 1 Tf
(Adherence )Tj
0 -1.38187 TD
(section)Tj
0 0 0 rg
/TT1 1 Tf
( of this site.)Tj
/TT0 1 Tf
12.5 0 0 12.5 175.24001 332.22884 Tm
(As with any antiviral drug or antibiotic, try not to ever miss a dose.)Tj
/TT1 1 Tf
( If )Tj
0 -1.22711 TD
(you miss a dose and notice that you have done so within a few hours of )Tj
0 -1.2 TD
(its scheduled time, you may take the dose as usual and take the next )Tj
T*
(dose at its regular time. )Tj
12.92308 0 0 12.92308 175.24001 252.52792 Tm
(It is very important that you NOT stop this medicine suddenly without )Tj
T*
(substituting other medications first. If you you do no substitute other\
)Tj
T*
(medications for a couple of weeks, your virus might develop resistance )Tj
T*
(to nevirapine and the entire class of non-nukes. Your provider can help\
)Tj
T*
(you with this process.)Tj
/TT0 1 Tf
12.5 0 0 12.5 175.24001 156.69037 Tm
(If you miss more than one dose, look at the reasons why you missed )Tj
0 -1.22711 TD
(them and come up with a plan to avoid it in the future.)Tj
/TT1 1 Tf
( For example, if )Tj
0 -1.2271 TD
(you fell asleep too early, take the medicine earlier in the evening, wit\
h )Tj
0 -1.2 TD
(your later meal, set an alarm, or have someone appointed to wake you up \
)Tj
T*
(for your medicine. )Tj
0 -2.72 TD
(It is strongly recommended that you consider using weekly pill boxes and\
)Tj
0 -1.2 TD
(arrange all of your doses a week in advance. Buy a small pill box so th\
at )Tj
ET
EMC
/Artifact <>BDC
Q
0 0 0 rg
BT
/T1_0 1 Tf
9 0 0 9 18 7.17 Tm
(http://hivinfo.us/efavirenz.html \(1 of 3\)12/26/2004 8:48:22 AM)Tj
ET
EMC
endstream
endobj
36 0 obj 5197
endobj
37 0 obj<>stream
/Artifact <>BDC
0 0 0 rg
0 i
BT
/T1_0 1 Tf
0 Tc 0 Tw 0 Ts 100 Tz 0 Tr 9 0 0 9 18 780.17 Tm
(HIVInfo.us - Sustiva - efavirenz information)Tj
ET
EMC
/WebCaptureBG BMC
/WebCaptureFN <>BDC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
0.06667 0.06667 0.06667 rg
10 766 m
10 36 l
13 36 l
13 766 l
h
f
602 766 m
602 36 l
599 36 l
599 766 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
170.24001 766 m
170.24001 731 l
171.24001 732 l
171.24001 766 l
h
f
595 766 m
595 731 l
594 732 l
594 766 l
h
f
170.24001 731 m
595 731 l
594 732 l
171.24001 732 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
17 766 m
17 731 l
18 732 l
18 766 l
h
f
166.24001 766 m
166.24001 731 l
165.24001 732 l
165.24001 766 l
h
f
17 731 m
166.24001 731 l
165.24001 732 l
18 732 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
17 727 m
166.24001 727 l
165.24001 726 l
18 726 l
h
f
17 727 m
17 36 l
18 36 l
18 726 l
h
f
166.24001 727 m
166.24001 36 l
165.24001 36 l
165.24001 726 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
170.24001 727 m
595 727 l
594 726 l
171.24001 726 l
h
f
170.24001 727 m
170.24001 36 l
171.24001 36 l
171.24001 726 l
h
f
595 727 m
595 36 l
594 36 l
594 726 l
h
f
EMC
EMC
EMC
/Article <>BDC
q
0 18 612 756 re
W* n
0 0 0 rg
BT
/TT0 1 Tf
12.5 0 0 12.5 175.24001 755.30222 Tm
(you can carry a dose or two of your medicines with you in case you are )Tj
0 -1.2 TD
(away from home.)Tj
/TT1 1 Tf
15 0 0 15 22 405.01718 Tm
(Possible Side )Tj
T*
(Effects)Tj
/TT0 1 Tf
12.92308 0 0 12.92308 22 370.38806 Tm
(The package insert for )Tj
T*
(most drugs including )Tj
T*
(efavirenz is often )Tj
T*
(overwhelming and )Tj
T*
(scary with perhaps an )Tj
T*
(overemphasis on side )Tj
T*
(effects. We have )Tj
T*
(summarized the )Tj
T*
(important and more )Tj
T*
(common problems )Tj
T*
(here.)Tj
12.5 0 0 12.5 175.24001 711.30222 Tm
(Most people take efavirenz without many side effects.)Tj
0 -2.72 TD
(Possible side effects include dizziness, nightmares, nervousness, troubl\
e )Tj
0 -1.2 TD
(sleeping, rash, nausea, headache, muscle aches, or liver problems.)Tj
12.92308 0 0 12.92308 175.24001 627.94014 Tm
(Efavirenz should never be administered to pregnant women or women )Tj
T*
(who can become pregnant as it can cause birth defects.)Tj
/TT1 1 Tf
0 -2.64313 TD
(The most common side effect is central nervous system \(CNS\) )Tj
0 -1.22711 TD
(stimulation.)Tj
/TT0 1 Tf
( )Tj
12.5 0 0 12.5 254.94954 562.41705 Tm
(Some people compare taking efavirenz to drinking several )Tj
-6.37675 -1.23967 Td
(cups of coffee at one time. Therefore it may be important for you to fi\
rst )Tj
0 -1.2 TD
(take efavirenz on a weekend or non-workday so that you can gauge how )Tj
T*
(well you can function before you have to work while taking the drug. )Tj
T*
(Persons who require close attention to detail in their jobs \(pilots, ai\
r traffic )Tj
T*
(controllers, surgeons, taxi drivers, etc.\) should perhaps consider othe\
r )Tj
T*
(options besides efavirenz. The stimulation from efavirenz gradually )Tj
T*
(becomes more tolerable over the first two weeks for many people.)Tj
0 -2.72 TD
(Usually you will have blood tests done in the first month to look for th\
e )Tj
0 -1.2 TD
(beneficial effects of efavirenz and any side effects. )Tj
12.92308 0 0 12.92308 175.24001 373.55907 Tm
(None of these ill effects are permanent. They will go away if you are )Tj
T*
(instructed to stop taking the medication and other medications are )Tj
T*
(substituted.)Tj
0 -2.67024 TD
(Many minor side effects will either stay constant or get better with tim\
e. )Tj
0 -1.2 TD
(It is mainly the side effects that are severe or get worse that may caus\
e )Tj
T*
(significant health risks for you.)Tj
0 -2.67023 TD
(The rash that develops in some people that take efavirenz is usually a )Tj
0 -1.2 TD
(mild body rash. Most mild rashes will stay mild or even go away. The )Tj
T*
(rashes of major concern are the ones that get worse and worse, the )Tj
T*
(ones associated with fever, or the ones that are severe. Notify your )Tj
T*
(provider promptly for any rash. Do not stop the medication unless )Tj
T*
(instructed to do so by a healthcare provider familiar with efavirenz )Tj
0 -1.26631 TD
(usage.)Tj
/T1_0 1 Tf
14 0 0 14 214.03508 148.60986 Tm
( )Tj
/TT0 1 Tf
12.92308 0 0 12.92308 175.24001 113.88214 Tm
(Efavirenz can also cause inflammation of the liver which is called )Tj
0 -1.2 TD
(hepatitis. Mild hepatitis does not cause symptoms but it can be seen )Tj
T*
(on liver blood tests. Worse hepatitis causes loss of appetite, nausea )Tj
T*
(and vomiting, possibly turning the skin and eyes yellow \(jaundice\), da\
rk )Tj
T*
(\(cola-colored\) urine, and light colored stools. You should notify you\
r )Tj
ET
EMC
/Artifact <>BDC
Q
0 0 0 rg
BT
/T1_0 1 Tf
9 0 0 9 18 7.17 Tm
(http://hivinfo.us/efavirenz.html \(2 of 3\)12/26/2004 8:48:22 AM)Tj
ET
EMC
endstream
endobj
38 0 obj 5726
endobj
39 0 obj<>stream
/Artifact <>BDC
0 0 0 rg
0 i
BT
/T1_0 1 Tf
0 Tc 0 Tw 0 Ts 100 Tz 0 Tr 9 0 0 9 18 780.17 Tm
(HIVInfo.us - Sustiva - efavirenz information)Tj
ET
EMC
/WebCaptureBG BMC
/WebCaptureFN <>BDC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
0.06667 0.06667 0.06667 rg
10 766 m
10 254.91452 l
13 257.91452 l
13 766 l
h
f
602 766 m
602 254.91452 l
599 257.91452 l
599 766 l
h
f
10 254.91452 m
602 254.91452 l
599 257.91452 l
13 257.91452 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
170.24001 766 m
170.24001 619.9077 l
171.24001 620.9077 l
171.24001 766 l
h
f
595 766 m
595 619.9077 l
594 620.9077 l
594 766 l
h
f
170.24001 619.9077 m
595 619.9077 l
594 620.9077 l
171.24001 620.9077 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
17 766 m
17 619.9077 l
18 620.9077 l
18 766 l
h
f
166.24001 766 m
166.24001 619.9077 l
165.24001 620.9077 l
165.24001 766 l
h
f
17 619.9077 m
166.24001 619.9077 l
165.24001 620.9077 l
18 620.9077 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
17 615.9077 m
166.24001 615.9077 l
165.24001 614.9077 l
18 614.9077 l
h
f
17 615.9077 m
17 375.67912 l
18 376.67912 l
18 614.9077 l
h
f
166.24001 615.9077 m
166.24001 375.67912 l
165.24001 376.67912 l
165.24001 614.9077 l
h
f
17 375.67912 m
166.24001 375.67912 l
165.24001 376.67912 l
18 376.67912 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
170.24001 615.9077 m
595 615.9077 l
594 614.9077 l
171.24001 614.9077 l
h
f
170.24001 615.9077 m
170.24001 375.67912 l
171.24001 376.67912 l
171.24001 614.9077 l
h
f
595 615.9077 m
595 375.67912 l
594 376.67912 l
594 614.9077 l
h
f
170.24001 375.67912 m
595 375.67912 l
594 376.67912 l
171.24001 376.67912 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
17 371.67912 m
595 371.67912 l
594 370.67912 l
18 370.67912 l
h
f
17 371.67912 m
17 293.77252 l
18 294.77252 l
18 370.67912 l
h
f
595 371.67912 m
595 293.77252 l
594 294.77252 l
594 370.67912 l
h
f
17 293.77252 m
595 293.77252 l
594 294.77252 l
18 294.77252 l
h
f
EMC
q
0 18 612 756 re
W* n
/Artifact <>BDC
Q
17 289.77252 m
595 289.77252 l
594 288.77252 l
18 288.77252 l
h
f
17 289.77252 m
17 261.91452 l
18 262.91452 l
18 288.77252 l
h
f
595 289.77252 m
595 261.91452 l
594 262.91452 l
594 288.77252 l
h
f
17 261.91452 m
595 261.91452 l
594 262.91452 l
18 262.91452 l
h
f
EMC
EMC
EMC
/Article <>BDC
q
0 18 612 756 re
W* n
0 0 0 rg
BT
/TT0 1 Tf
12.92308 0 0 12.92308 175.24001 754.94014 Tm
(healthcare provider promptly if you have any of these symptoms so that )Tj
0 -1.26631 TD
(you can get liver tests done.)Tj
/T1_0 1 Tf
14 0 0 14 336.14523 738.57556 Tm
( )Tj
/TT0 1 Tf
12.5 0 0 12.5 175.24001 704.20992 Tm
(All drugs of this type can cause or contribute to abnormal fat redistrib\
ution )Tj
0 -1.2 TD
(characterized by thinning of the face, arms, or legs. In most cases thi\
s )Tj
T*
(would be also accompanied by elevated cholesterol levels, elevated )Tj
T*
(triglyceride levels, and perhaps a tendency to develop diabetes. )Tj
T*
(Efavirenz has less of a tendency to cause these problems than perhaps )Tj
T*
(the nukes \(NRTIs\) or protease inhibitors.)Tj
/TT1 1 Tf
15 0 0 15 22 538.88576 Tm
(Interactions)Tj
/TT0 1 Tf
12.92308 0 0 12.92308 22 522.25662 Tm
(This refers to the way )Tj
T*
(that efavirenz affects )Tj
T*
(other medications and )Tj
T*
(how other drugs affect )Tj
T*
(efavirenz in the )Tj
T*
(bloodstream.)Tj
/TT1 1 Tf
11.85785 11.93777 Td
(Certain drugs )Tj
1 0 0 rg
(should not be given)Tj
0 0 0 rg
( with efavirenz:)Tj
/T1_0 1 Tf
14 0 0 14 478.27322 598.99094 Tm
( )Tj
/TT1 1 Tf
12.92308 0 0 12.92308 175.24001 564.13295 Tm
(Antihistamines: )Tj
/TT0 1 Tf
(astemizole)Tj
/TT1 1 Tf
0 -1.22711 TD
(GI motility drugs: )Tj
/TT0 1 Tf
(cisapride)Tj
/TT1 1 Tf
0 -1.2271 TD
(Seadatives: )Tj
/TT0 1 Tf
(midazolam, triazolam)Tj
/TT1 1 Tf
0 -1.22711 TD
(Migraine treatment or prevention: )Tj
/TT0 1 Tf
(ergot derivatives)Tj
/TT1 1 Tf
T*
(Fungal treatment)Tj
/TT0 1 Tf
(: voriconazole)Tj
/TT1 1 Tf
0 -1.2271 TD
(Herbal therapy)Tj
/TT0 1 Tf
(: St Johns wort)Tj
/TT1 1 Tf
12.5 0 0 12.5 175.24001 450.68587 Tm
(Efavirenz increases the metabolism \(breakdown\) of certain drugs so )Tj
0 -1.2 TD
(that )Tj
1 0 0 rg
(dose adjustments, boosting, or substitutions may be necessary)Tj
0 0 0 rg
(:)Tj
12.92308 0 0 12.92308 175.24001 400.98495 Tm
(Protease inhibitors: )Tj
/TT0 1 Tf
(indinavir \(Crixivan\), atazanavir \(Reyataz\), )Tj
0 -1.22711 TD
(lopinavir/ritonavir \(Kaletra\))Tj
1 0 0 rg
/TT1 1 Tf
15 0 0 15 22 353.84178 Tm
(Report to you healthcare provider or go to an Emergency Room)Tj
/TT0 1 Tf
( )Tj
0 0 0 rg
13.75 0 0 13.75 480.42999 353.84178 Tm
(if you have rash, )Tj
-33.34036 -1.26086 Td
(severe side effects, increasing side effects, shortness of breath, uncon\
trollable diarrhea, )Tj
0 -1.2 TD
(fever, weakness, jaundice \(eyes and skin turn yellow,\) muscle pain, na\
usea and vomiting so )Tj
T*
(that you cannot hold down your food and liquids.)Tj
12.92308 0 0 12.92308 22 273.71266 Tm
(You can download this handout in PDF format by clicking )Tj
0.50197 0 0.50197 rg
/TT1 1 Tf
(HERE)Tj
0 0 0 rg
/TT0 1 Tf
(.)Tj
10 0 0 10 10 227.35629 Tm
(12.26.2004)Tj
ET
EMC
/Artifact <>BDC
Q
0 0 0 rg
BT
/T1_0 1 Tf
9 0 0 9 18 7.17 Tm
(http://hivinfo.us/efavirenz.html \(3 of 3\)12/26/2004 8:48:22 AM)Tj
ET
EMC
endstream
endobj
40 0 obj(HIVInfo.us - Sustiva - efavirenz information)
endobj
41 0 obj<>
endobj
42 0 obj<>
endobj
43 0 obj<>
endobj
44 0 obj<>
endobj
45 0 obj[42 0 R]
endobj
46 0 obj(http://hivinfo.us/efavirenz.html)
endobj
47 0 obj(+8:?5)
endobj
48 0 obj<>
endobj
49 0 obj<>
endobj
50 0 obj(I֍\\_`)
endobj
51 0 obj<>
endobj
52 0 obj<>
endobj
53 0 obj<>
endobj
54 0 obj<>
endobj
55 0 obj<>
endobj
56 0 obj<>stream
HIVInfo.us - Sustiva - efavirenz information
endstream
endobj
xref
0 57
0000000004 65535 f
0000000016 00000 n
0000000159 00000 n
0000000224 00000 n
0000000000 00001 f
0000000394 00000 n
0000000414 00000 n
0000000480 00000 n
0000000580 00000 n
0000000624 00000 n
0000000671 00000 n
0000000794 00000 n
0000000999 00000 n
0000001162 00000 n
0000001286 00000 n
0000001362 00000 n
0000001451 00000 n
0000002642 00000 n
0000002687 00000 n
0000002740 00000 n
0000002764 00000 n
0000002937 00000 n
0000003109 00000 n
0000003274 00000 n
0000003465 00000 n
0000003489 00000 n
0000003694 00000 n
0000003718 00000 n
0000003891 00000 n
0000003915 00000 n
0000004005 00000 n
0000005182 00000 n
0000005356 00000 n
0000006529 00000 n
0000006697 00000 n
0000006718 00000 n
0000016122 00000 n
0000016143 00000 n
0000021393 00000 n
0000021414 00000 n
0000027193 00000 n
0000027255 00000 n
0000027291 00000 n
0000027358 00000 n
0000027387 00000 n
0000027496 00000 n
0000027520 00000 n
0000027570 00000 n
0000027604 00000 n
0000027729 00000 n
0000027780 00000 n
0000027815 00000 n
0000027858 00000 n
0000027899 00000 n
0000027940 00000 n
0000028024 00000 n
0000028148 00000 n
trailer
<]>>
startxref
31491
%%EOF
1 0 obj<>/StructTreeRoot 7 0 R/Metadata 58 0 R/SpiderInfo 41 0 R>>
endobj
3 0 obj<>
endobj
57 0 obj null
endobj
58 0 obj<>stream
HIVInfo.us - Sustiva - efavirenz informationHIVInfo.us - Sustiva - efavirenz informationHIVInfo.us
endstream
endobj
xref
1 1
0000032786 00000 n
3 1
0000032972 00000 n
57 2
0000033270 00000 n
0000033291 00000 n
trailer
<<8f21389d56e26f46b1d0a30bc36b54ad>]/Prev 31491 >>
startxref
36899
%%EOF